Evaluation reports
EN
Innovations thérapeutiques en hémostase
Type: Research unit evaluation report
Evaluation campaign: 2017-2018 (group D)
- Published on: 01/06/2018
Institution(s) concerned:
Université Paris Descartes
, Institut national de la santé et de la recherche médicale - INSERM
Disciplinary research field: Life and Earth Sciences (SVE) ; SVE5 Physiology, Physiopathology, Cardiology, Pharmacology, Enocrinology, Cancer, Medical Technologies
Scientific field(s): 5 - Biologie, medecine et santé
ERC panel(s): LS7 Diagnostic tools, therapies and public health: aetiology, diagnosis and treatment of disease, public health, epidemiology, pharmacology, clinical medicine, regenerative medicine, medical ethics ; LS4 Physiology, Pathophysiology and Endocrinology: organ physiology, pathophysiology, endocrinology, metabolism, ageing, regeneration, tumorigenesis, cardiovascular disease, metabolic syndrome
Keywords: Hémostase ; hémocompatibilité ; médicaments antithrombotiques ; plaquettes ; progéniteurs endothéliaux